CITIGROUP INC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 203 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,672
-99.2%
1,313
-98.9%
0.00%
Q2 2023$755,346
-49.9%
114,620
-48.3%
0.00%
-100.0%
Q1 2023$1,506,362
+88.7%
221,850
+105.4%
0.00%0.0%
Q4 2022$798,371
-49.5%
108,034
-32.4%
0.00%0.0%
Q3 2022$1,580,000
+23.4%
159,919
+36.1%
0.00%0.0%
Q2 2022$1,280,000
+37.3%
117,479
+42.6%
0.00%0.0%
Q1 2022$932,000
-60.9%
82,384
-45.8%
0.00%0.0%
Q4 2021$2,383,000
+48.9%
151,874
+62.7%
0.00%0.0%
Q3 2021$1,600,000
-46.5%
93,356
-32.8%
0.00%
-50.0%
Q2 2021$2,988,000
+3.1%
138,916
-28.0%
0.00%0.0%
Q1 2021$2,898,000
+1223.3%
192,936
+1062.1%
0.00%
Q4 2020$219,000
+195.9%
16,602
+116.5%
0.00%
Q3 2020$74,000
-89.3%
7,667
-87.3%
0.00%
-100.0%
Q2 2020$692,000
+40.7%
60,543
+27.4%
0.00%
Q1 2020$492,000
-4.5%
47,540
+51.4%
0.00%
Q4 2019$515,000
-69.9%
31,390
-75.6%
0.00%
-100.0%
Q3 2019$1,710,000
-2.1%
128,704
+3.8%
0.00%0.0%
Q2 2019$1,746,000
+28.9%
123,944
+68.4%
0.00%0.0%
Q1 2019$1,355,000
-40.1%
73,618
-15.0%
0.00%
-50.0%
Q4 2018$2,263,000
+71.2%
86,603
+50.4%
0.00%
+100.0%
Q3 2018$1,322,000
+1147.2%
57,592
+931.2%
0.00%
Q2 2018$106,000
-38.0%
5,585
-44.8%
0.00%
Q1 2018$171,000
-88.2%
10,125
-89.4%
0.00%
-100.0%
Q4 2017$1,448,000
-41.9%
95,271
-31.6%
0.00%
-50.0%
Q3 2017$2,494,000
+204.9%
139,353
+177.8%
0.00%
+100.0%
Q2 2017$818,000
+27.2%
50,163
+9.3%
0.00%
Q1 2017$643,000
-72.0%
45,900
-68.1%
0.00%
-100.0%
Q4 2016$2,295,000
+353.6%
143,887
+372.5%
0.00%
Q3 2016$506,000
+406.0%
30,455
+241.2%
0.00%
Q2 2016$100,000
-69.7%
8,926
-77.4%
0.00%
Q1 2016$330,000
+345.9%
39,540
+397.9%
0.00%
Q4 2015$74,000
-86.3%
7,942
-83.4%
0.00%
Q3 2015$540,000
+248.4%
47,839
+291.8%
0.00%
Q2 2015$155,000
+98.7%
12,209
+45.1%
0.00%
Q1 2015$78,000
-64.4%
8,413
-45.0%
0.00%
Q4 2014$219,000
+1725.0%
15,306
+1198.2%
0.00%
Q3 2014$12,000
-83.1%
1,179
-73.1%
0.00%
Q2 2014$71,000
-49.3%
4,389
-48.9%
0.00%
Q1 2014$140,000
-13.6%
8,588
-34.4%
0.00%
Q4 2013$162,000
+58.8%
13,095
+40.6%
0.00%
Q3 2013$102,000
+385.7%
9,311
+271.4%
0.00%
Q2 2013$21,0002,5070.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders